Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EBT (2016 - 2026)

Biomerica's EBT history spans 17 years, with the latest figure at -$1.3 million for Q1 2026.

  • Quarterly results put EBT at -$1.3 million for Q1 2026, down 11.74% from a year ago — trailing twelve months through Feb 2026 was -$4.2 million (up 14.3% YoY), and the annual figure for FY2025 was -$5.0 million, up 16.24%.
  • EBT for Q1 2026 was -$1.3 million at Biomerica, up from -$1.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $5000.0 in Q3 2025 to a low of -$2.1 million in Q3 2022.
  • The 5-year median for EBT is -$1.4 million (2024), against an average of -$1.3 million.
  • The sharpest move saw EBT crashed 1491.45% in 2023, then surged 100.38% in 2025.
  • Year by year, EBT stood at -$1.6 million in 2022, then increased by 7.75% to -$1.5 million in 2023, then skyrocketed by 36.42% to -$953000.0 in 2024, then crashed by 37.99% to -$1.3 million in 2025, then grew by 0.84% to -$1.3 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at -$1.3 million, -$1.3 million, and $5000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.